Journal History
2013 | The inaugural issue is released, and Vaccines published as a quarterly journal. |
2015 | Indexed by Scopus (Elsevier), PubMed (NLM) and Emerging Sources Citation Index (ESCI, Web of Science). Full-text papers are archived in the US National Library of Medicine's (NLM) PubMed Central (PMC). |
2017 | Vaccines launched its first edition of Travel Awards. The journal Twitter account was established. |
2018 | Indexed by the Science Citation Index Expanded (SCIE – Web of Science) and BIOSIS Previews (Web of Science). |
2019 | Vaccines received a first Impact Factor of 4.76. The journal ranks 39/158 (Q1) in the 'Immunology' category and 25/136 (Q1) in the "Medicine, Research & Experimental" category. |
2020 | Vaccines published its 1000th paper. Vaccines established the following Sections: Vaccine adjuvants Attenuated/Inactivated/Live and Vectored vaccines Clinical Immunology Cellular/molecular Immunology Pathogens-host Immune Interface Human Papillomavirus Vaccines Hepatitis Virus Vaccines |
2021 | Vaccines established the following Sections: COVID-19 Vaccines and Vaccination PK/PD (Pharmacokinetic/Pharmacodynamic Modeling) Approaches for Vaccination Optimization DNA and mRNA Vaccines |
Editors-in-Chief
2013–2019 | Editor-in-Chief: Prof. Dr. Diane M. Harper |
2019–present | Editor-in-Chief: Prof. Dr. Ralph A. Tripp |
Section Editor-in-Chief
2019-present | Section-Editor-in-Chief: Dr. Subbaya Subramanian for the section on Cancer Vaccines and Immunotherapy |
Section-Editor-in-Chief: Dr. Romain Paillot for the section on Veterinary Vaccines | |
Section-Editor-in-Chief: Prof. Dr. Giuseppe La Torre for the section on Epidemiology | |
Section-Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on Vaccines against (re)emerging and Tropical Infections Diseases | |
Section-Editor-in-Chief: Prof. Dr. Martin F. Bachmann for the section on Therapeutic Vaccines and Antibody Therapeutics | |
2020-present | Section-Editor-in-Chief: Dr. Yee-Joo Tan for the section on Hepatitis Virus Vaccines |
Section-Editor-in-Chief: Prof. Dr. François Meurens for the section on Pathogens-host Immune Interface | |
Section-Editor-in-Chief: Prof. Dr. Hans-Peter Hartung for the section on Cellular/Molecular Immunology | |
Section-Editor-in-Chief: Dr. Eduardo Gomez-Casado for the section on Vaccine Adjuvants | |
Section-Editor-in-Chief: Prof. Dr. Giampiero Girolomoni for the section on Clinical Immunology | |
Section-Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on HIV Vaccines | |
2021-present | Section-Editor-in-Chief: Prof. Dr. Luis Martinez-Sobrido for the section on COVID-19 Vaccines and Vaccination |
Section-Editor-in-Chief: Prof. Dr. Hinh Ly for the section on Innate and Adaptive Immunity in Vaccination | |
Section-Editor-in-Chief: Prof. Dr. Jorge H. Leitão for the section on DNA and mRNA Vaccines | |
Section-Editor-in-Chief: Prof. Dr. Amine A. Kamen for the section on Attenuated/Inactivated/Live and Vectored Vaccines | |
Section-Editor-in-Chief: Dr. Ralph J. DiClemente for the section on Vaccines and Society |